ALS Invest 1 B.V., 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 121,218 shares at $19.54 ($2.5M) on 2022-07-06, disclosed to the SEC on 2022-07-08.
Open-market sale of $2.5M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.54 | 18,312 | $358K | 14.3% |
| 2 | $19.54 | 18,312 | $358K | 14.3% |
| 3 | $20.60 | 10,395 | $214K | 8.5% |
| 4 | $20.60 | 10,395 | $214K | 8.5% |
| 5 | $21.32 | 29,595 | $631K | 25.1% |
| 6 | $21.32 | 29,595 |
| $631K |
| 25.1% |
| 7 | $22.42 | 2,307 | $52K | 2.1% |
| 8 | $22.42 | 2,307 | $52K | 2.1% |
| Total | $20.70 avg | 121,218 | $2.5M | 100% |